ATE348837T1 - Neue 14- und 15-gliedrige ringverbindungen - Google Patents

Neue 14- und 15-gliedrige ringverbindungen

Info

Publication number
ATE348837T1
ATE348837T1 AT04732108T AT04732108T ATE348837T1 AT E348837 T1 ATE348837 T1 AT E348837T1 AT 04732108 T AT04732108 T AT 04732108T AT 04732108 T AT04732108 T AT 04732108T AT E348837 T1 ATE348837 T1 AT E348837T1
Authority
AT
Austria
Prior art keywords
new
link ring
ring connections
connections
link
Prior art date
Application number
AT04732108T
Other languages
German (de)
English (en)
Inventor
Sulejman Alihodzic
John Michael Berge
Richard Lewis Jarvest
Original Assignee
Glaxo Group Ltd
Pliva Istrazivacki Inst D O O
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0310962A external-priority patent/GB0310962D0/en
Priority claimed from GB0407391A external-priority patent/GB0407391D0/en
Application filed by Glaxo Group Ltd, Pliva Istrazivacki Inst D O O filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of ATE348837T1 publication Critical patent/ATE348837T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AT04732108T 2003-05-13 2004-05-11 Neue 14- und 15-gliedrige ringverbindungen ATE348837T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0310962A GB0310962D0 (en) 2003-05-13 2003-05-13 Novel compounds
GB0407391A GB0407391D0 (en) 2004-03-31 2004-03-31 Novel compounds

Publications (1)

Publication Number Publication Date
ATE348837T1 true ATE348837T1 (de) 2007-01-15

Family

ID=33454579

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04732108T ATE348837T1 (de) 2003-05-13 2004-05-11 Neue 14- und 15-gliedrige ringverbindungen

Country Status (15)

Country Link
US (1) US20070293472A1 (enExample)
EP (1) EP1628989B1 (enExample)
JP (1) JP2006528667A (enExample)
AR (1) AR044304A1 (enExample)
AT (1) ATE348837T1 (enExample)
CA (1) CA2525455A1 (enExample)
CL (1) CL2004001012A1 (enExample)
DE (1) DE602004003809T2 (enExample)
DK (1) DK1628989T3 (enExample)
ES (1) ES2278319T3 (enExample)
HR (1) HRP20070094T3 (enExample)
PL (1) PL1628989T3 (enExample)
PT (1) PT1628989E (enExample)
SI (1) SI1628989T1 (enExample)
WO (1) WO2004101587A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7601695B2 (en) 2003-03-10 2009-10-13 Optimer Pharmaceuticals, Inc. Antibacterial agents
AU2005240849B2 (en) * 2004-05-06 2008-10-23 Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. Ester linked macrolides useful for the treatment of microbial infections
GB0424961D0 (en) * 2004-11-11 2004-12-15 Glaxo Group Ltd Novel compounds
WO2007054295A1 (en) * 2005-11-09 2007-05-18 Glaxo Group Limited New 4*-substituted erythromycin derivative
GB0424958D0 (en) * 2004-11-11 2004-12-15 Glaxo Group Ltd Novel compounds
JP2008540503A (ja) 2005-05-10 2008-11-20 グラクソスミスクライン・イストラジヴァッキ・センタル・ザグレブ・ドルズバ・ゼー・オメイェノ・オドゴヴォルノスティオ 細菌感染症の処置に有用なエーテル結合マクロライド
WO2007054296A1 (en) * 2005-11-09 2007-05-18 Glaxo Group Limited Macrolones
AU2008316830B2 (en) 2007-10-25 2016-03-17 Cempra Pharmaceuticals, Inc. Process for the preparation of macrolide antibacterial agents
CN107854477A (zh) 2008-10-24 2018-03-30 森普拉制药公司 使用含三唑的大环内酯治疗抗性疾病的方法
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
US9480679B2 (en) 2009-09-10 2016-11-01 Cempra Pharmaceuticals, Inc. Methods for treating malaria, tuberculosis and MAC diseases
BR112012029586A2 (pt) * 2010-05-20 2016-08-02 Cempra Pharmaceuticals Inc processos para preparar macrolídeos e cetolídeos e intermediários dos mesmos
KR20130120458A (ko) 2010-09-10 2013-11-04 셈프라 파마슈티컬스, 인크. 질환을 치료하기 위한 수소결합 형성 플루오로 케토라이드
WO2013148891A1 (en) 2012-03-27 2013-10-03 Cempra Pharmaceuticals, Inc. Parenteral formulations for administering macrolide antibiotics
WO2014152326A1 (en) 2013-03-14 2014-09-25 Cempra Pharmaceuticals, Inc. Methods for treating respiratory diseases and formulations therefor
AU2014233240B2 (en) 2013-03-15 2018-08-09 Cempra Pharmaceuticals, Inc. Convergent processes for preparing macrolide antibacterial agents

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4180654A (en) * 1978-01-03 1979-12-25 Pfizer Inc. 4"-Deoxy-4"-acylamido derivatives of oleandomycin, erythromycin and erythromycin carbonate
US4512982A (en) * 1984-04-13 1985-04-23 Pfizer Inc. 9α-Aza-9α-homoerythromycin compounds, pharmaceutical composition and therapeutic method
US4686207A (en) * 1985-11-12 1987-08-11 Abbott Laboratories Erythromycin A 11,12-carbonates and method of use
IL93936A (en) * 1989-03-28 1994-06-24 Abbott Lab History of 9-dioxo-21,9-epoxy - erythromycin, method of preparation History of 11-oxo and 11-hydroxy, and pharmaceutical preparations containing them
WO1996034007A1 (es) * 1995-04-27 1996-10-31 Laboratorios Aranda, S.A. De C.V. Derivados de quinolonilcarboxieritromicina y composiciones farmaceuticas que los contienen
DE69723848T2 (de) * 1996-05-07 2004-07-01 Abbott Laboratories, Abbott Park 3-descladinose-2,3-anhydroerythromycin-derivate
EP0895999A1 (en) * 1997-08-06 1999-02-10 Pfizer Products Inc. C-4" substituted macrolide antibiotics
GB0025688D0 (en) * 2000-10-19 2000-12-06 Glaxo Group Ltd Macrolides
JP4311203B2 (ja) * 2001-08-08 2009-08-12 大正製薬株式会社 １１ａ−アザライド化合物及びその製造方法
GB0127349D0 (en) * 2001-11-14 2002-01-02 Glaxo Group Ltd Macrolides
GB0225384D0 (en) * 2002-10-31 2002-12-11 Glaxo Group Ltd Novel compounds

Also Published As

Publication number Publication date
PL1628989T3 (pl) 2007-05-31
ES2278319T3 (es) 2007-08-01
PT1628989E (pt) 2007-03-30
DE602004003809D1 (de) 2007-02-01
EP1628989A1 (en) 2006-03-01
HRP20070094T3 (hr) 2008-05-31
US20070293472A1 (en) 2007-12-20
EP1628989B1 (en) 2006-12-20
WO2004101587A1 (en) 2004-11-25
SI1628989T1 (sl) 2007-06-30
CA2525455A1 (en) 2004-11-25
DK1628989T3 (da) 2007-10-08
DE602004003809T2 (de) 2007-10-11
AR044304A1 (es) 2005-09-07
CL2004001012A1 (es) 2005-03-18
JP2006528667A (ja) 2006-12-21

Similar Documents

Publication Publication Date Title
FI20010157L (fi) Probioottiyhdistelmä
PT1411764E (pt) Cerca
DE10295851T1 (de) Dachfensterbaueinheit und Einzelteile
DE60328671D1 (de) Neue aminobenzamidderivate
DE50211353D1 (de) Dichtungsanordnung
DE60204105D1 (de) Wärmeverträgliche Dichtung
DE60233444D1 (de) Teileanbringvorrichtung und teileanbringverfahren
ATE420642T1 (de) Neue formulierungen und ihre verwendung
DE60316588D1 (de) Neue lactame und deren verwendungen
DE60336306D1 (de) Photoinitiator, neue verbindung und photohärtbare zusammensetzung
DK1239199T3 (da) Ventilindretning
DE602004003809D1 (de) Neue 14- und 15-gliedrige ringverbindungen
FR2830063B1 (fr) Joint homocinetique
DE60221576D1 (de) Lötlegierung und lötverbindung
ATE341560T1 (de) Neue 14- und 15-gliedrige ringverbindungen
DE60334907D1 (de) Neue phthalamidderivate
DE60203475D1 (de) Drosselklappe und Drossel
ATE450543T1 (de) Neue 14- und 15-gliedrige ringverbindungen
EP1390074A4 (en) NEW COMPOSITIONS AND ITS USES
ATE378347T1 (de) Neue 14- und 15-gliedrige ringverbindungen
DE50213801D1 (de) Gelenk
DE60232344D1 (de) Neue formulierungen und ihre verwendung
ATE299873T1 (de) Substituierte c-furan-2-yl-methylamin- und c- thiophen-2-yl-methylamin-derivate
DE50309081D1 (de) Neue diketopyrrolopyrrolpigmente
FI20011346L (fi) Tiivistejärjestely

Legal Events

Date Code Title Description
EEFA Change of the company name
UEP Publication of translation of european patent specification

Ref document number: 1628989

Country of ref document: EP

REN Ceased due to non-payment of the annual fee